Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Apyx Medical Corp | a2019q410-kexhibit322.htm |
| EX-31.2 - EXHIBIT 31.2 - Apyx Medical Corp | a2019q410-kexhibit312.htm |
| EX-31.1 - EXHIBIT 31.1 - Apyx Medical Corp | a2019q410-kexhibit311.htm |
| EX-23.2 - EXHIBIT 23.2 - Apyx Medical Corp | exhibit232fdconsent.htm |
| EX-23.1 - EXHIBIT 23.1 - Apyx Medical Corp | exhibit231bdoconsent.htm |
| EX-21.1 - EXHIBIT 21.1 - Apyx Medical Corp | a2019q410-kexhibit211.htm |
| EX-14.1 - EXHIBIT 14.1 - Apyx Medical Corp | apyxmedicalcodeofbusines.htm |
| EX-4.2 - EXHIBIT 4.2 - Apyx Medical Corp | apyxdescriptionofsecurit.htm |
| 10-K - 10-K - Apyx Medical Corp | a2019q410-k.htm |
EXHIBIT 32.1
Certificate Pursuant to 18 U.S.C Section 1350, as adopted pursuant to
Section 906 of Sarbanes – Oxley Act of 2002
CERTIFICATION OF CEO
In connection with the annual report on Form 10-K of Apyx Medical Corporation (the "Company") for the period ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned Chief Executive Officer certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 31, 2020 | By: | /s/ Charles D. Goodwin II | |
Charles D. Goodwin II | |||
President and Chief Executive Officer | |||